On the stock market since 2011, it operates in the world of health and science. It has 1,760 employees. Now — the numbers.
This is an established company with proven profits.
An average decline of 5% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
If every debt were paid off today, $44.5M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Revenue Growth: Sales are growing slowly.
The stock trades below its recent peak — about 10% off the top. A pullback, not a collapse.
The net profit margin is 56% — still a thick cushion, though costs have been eating into it lately.
There is $46.3M in the vault; even if every debt were paid off, $44.5M would remain.
Over the last 3 years, sales fell about 9% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The company’s market value is 38 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, ABCZF sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ABCZF is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.